World Pharma AI · London Edition

World Pharma AI · London
2027.

Next-Gen Drug Discovery.

The premier conference series for life-science leaders, R&D directors, and AI scientists examining how machine intelligence is compressing discovery timelines, reshaping clinical trials, and unlocking precision medicine at population scale.

Doors open in

––
Days
––
Hours
––
Mins
––
Secs
Register NowView SpeakersVisit Website

150+

Delegates

25+

Speakers

1

Day

Date

28 April 2027

Venue

Central London

Format

In-person Panel Based Discussions

Series

World Pharma AI

The London Edition

One day. The whole
pharma AI field.

6 focus areas, mapped to the decisions senior leaders face right now.

01

From Target to Candidate

Scaling AI-Driven Drug Discovery

  • Where AI is shortening hit-to-lead and candidate selection, and what has reached the clinic so far
  • What UK data assets — UK Biobank, Genomics England — change about target identification
  • How big pharma partners with AI-native biotechs: deal structures, IP and how success is judged
02

Smarter Clinical Trials

Design, Recruitment & Execution

  • Protocol optimisation, digital twins and synthetic control arms: what MHRA, EMA and FDA will accept
  • Finding patients faster through NHS data, DigiTrials and real-world evidence
  • AI-authored protocols, ICFs and study reports: where human sign-off has to stay
03

Data Foundations & Governance

AI at Enterprise Scale

  • Making legacy R&D, clinical and commercial data AI-ready: master data, lineage and quality
  • Federated and privacy-preserving approaches to patient data across trusts and borders
  • Model ownership, validation and lifecycle monitoring inside a quality system
04

Agentic AI in Regulatory & Safety

Submissions, PV & Medical Writing

  • Agents in submissions, MLR review and pharmacovigilance case processing: real deployments and results
  • Evaluating and guardrailing autonomous systems in a GxP environment
  • Preparing for the FDA and EMA Good AI Practice principles, the EU AI Act and MHRA expectations
05

Commercial & Medical Affairs

Omnichannel, Agents & the Voice Channel

  • Next best action, HCP segmentation and omnichannel orchestration that proves ROI
  • Voice and agentic AI in the field and the contact centre: MSL copilots, medical information and AE intake
  • Compliance guardrails for AI-generated content under the ABPI Code and PMCPA
06

Beyond Pilots

The AI Operating Model & Workforce

  • Why most GenAI pilots stall, and what the programmes that reached production did differently
  • Central AI team versus federated teams: governance, funding and how value is measured
  • Building AI fluency across R&D, clinical, regulatory and commercial functions

Location

Central London

Central London, London, United Kingdom
Exact address confirmed with your pass.

Passes

Secure your place.

Pharma & Biotech Ticket

Complimentary pass for C-Suite Executives & Directors. Subject to confirmation.

Free

Who qualifies

  • Pharmaceutical Manufacturers (AstraZeneca, Pfizer, GSK)
  • Biotechnology & Life-Science Companies
  • Contract Research Organisations (CROs)
  • Academic & Research Institutions
  • Regulators & Health Authorities (MHRA, EMA)
  • NHS Trusts & Clinical Trial Units
First release

Delegate Pass

Vendors (Service Providers)

£699per ticket

Includes

  • Full-day conference access
  • All keynotes & panel sessions
  • Networking & exhibition floor
  • Hot lunch buffet, refreshments & drinks reception

Sponsors

Partnership & exhibition packages for solution providers.

Bespoke

Opportunities include

  • Exhibition space on the networking floor
  • Speaking & panel opportunities
  • 1-1 meetings
  • Spotlight presentations
  • Brand visibility — digital, print & on-site